Project Details
| Status | Active |
|---|---|
| Effective start/end date | 23/05/19 → 31/12/26 |
Keywords
- Malignant Haematology
- Acute Myeloid Leukaemia (AML)
- Myelodysplastic syndrome
- Clinical trial
Clinical Trial Phase
- Phase I
A phase 1b, multi-arm, open-label, study of HDM201 in combination with MBG453 or venetoclax in adult subjects with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS).
- Flemming, Shaun (Primary Chief Investigator (PCI))
- Wei, Andrew (Chief Investigator (CI))
- Kennedy, Nola (Chief Investigator (CI))
Project: Research